Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications.

Sar A, Duan Q, Khalil M, DiFrancesco LM, Ewanowich C, Lytwyn A, Djordjevic B, Itani D, Lee S, Köbel M, Glaze S, Park E, Duggan MA.

J Low Genit Tract Dis. 2018 Apr;22(2):132-138. doi: 10.1097/LGT.0000000000000380.

PMID:
29474242
2.

Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.

Hoang LN, Kinloch MA, Leo JM, Grondin K, Lee CH, Ewanowich C, Köbel M, Cheng A, Talhouk A, McConechy M, Huntsman DG, McAlpine JN, Soslow RA, Gilks CB.

Am J Surg Pathol. 2017 Feb;41(2):245-252. doi: 10.1097/PAS.0000000000000764.

PMID:
28079598
3.

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

Köbel M, Rahimi K, Rambau PF, Naugler C, Le Page C, Meunier L, de Ladurantaye M, Lee S, Leung S, Goode EL, Ramus SJ, Carlson JW, Li X, Ewanowich CA, Kelemen LE, Vanderhyden B, Provencher D, Huntsman D, Lee CH, Gilks CB, Mes Masson AM.

Int J Gynecol Pathol. 2016 Sep;35(5):430-41. doi: 10.1097/PGP.0000000000000274.

4.

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.

Köbel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, Thiel FC, Hartmann A, Wachter DL, Anglesio MS, Høgdall E, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Fogarty ZC, Vierkant RA, Liu S, Cho S, Nelson G, Ghatage P, Gentry-Maharaj A, Gayther SA, Benjamin E, Widschwendter M, Intermaggio MP, Rosen B, Bernardini MQ, Mackay H, Oza A, Shaw P, Jimenez-Linan M, Driver KE, Alsop J, Mack M, Koziak JM, Steed H, Ewanowich C, DeFazio A, Chenevix-Trench G, Fereday S, Gao B, Johnatty SE, George J, Galletta L; AOCS Study Group, Goode EL, Kjær SK, Huntsman DG, Fasching PA, Moysich KB, Brenton JD, Kelemen LE.

Br J Cancer. 2014 Dec 9;111(12):2297-307. doi: 10.1038/bjc.2014.567. Epub 2014 Oct 30.

5.

Targeted mutation analysis of endometrial clear cell carcinoma.

Hoang LN, McConechy MK, Meng B, McIntyre JB, Ewanowich C, Gilks CB, Huntsman DG, Köbel M, Lee CH.

Histopathology. 2015 Apr;66(5):664-74. doi: 10.1111/his.12581. Epub 2015 Jan 13.

PMID:
25308272
6.

HNF-1β in ovarian carcinomas with serous and clear cell change.

DeLair D, Han G, Irving JA, Leung S, Ewanowich CA, Longacre TA, Gilks CB, Soslow RA.

Int J Gynecol Pathol. 2013 Nov;32(6):541-6. doi: 10.1097/PGP.0b013e318273fd07.

7.

Reproducibility of histological cell type in high-grade endometrial carcinoma.

Han G, Sidhu D, Duggan MA, Arseneau J, Cesari M, Clement PB, Ewanowich CA, Kalloger SE, Köbel M.

Mod Pathol. 2013 Dec;26(12):1594-604. doi: 10.1038/modpathol.2013.102. Epub 2013 Jun 28.

8.

Managing a solitary fibrous tumour of the diaphragm from above and below.

Hunt I, Ewanowich C, Reid A, Stewart K, Bédard EL, Valji A.

ANZ J Surg. 2010 May;80(5):370-1. doi: 10.1111/j.1445-2197.2010.05282.x. No abstract available.

PMID:
20557515
9.

Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study.

Köbel M, Kalloger SE, Baker PM, Ewanowich CA, Arseneau J, Zherebitskiy V, Abdulkarim S, Leung S, Duggan MA, Fontaine D, Parker R, Huntsman DG, Gilks CB.

Am J Surg Pathol. 2010 Jul;34(7):984-93. doi: 10.1097/PAS.0b013e3181e1a3bb.

PMID:
20505499
10.

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.

Köbel M, Xu H, Bourne PA, Spaulding BO, Shih IeM, Mao TL, Soslow RA, Ewanowich CA, Kalloger SE, Mehl E, Lee CH, Huntsman D, Gilks CB.

Mod Pathol. 2009 Mar;22(3):469-75. doi: 10.1038/modpathol.2008.206. Epub 2009 Jan 9.

11.

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.

Köbel M, Kalloger SE, Carrick J, Huntsman D, Asad H, Oliva E, Ewanowich CA, Soslow RA, Gilks CB.

Am J Surg Pathol. 2009 Jan;33(1):14-21. doi: 10.1097/PAS.0b013e3181788546.

PMID:
18830127
12.

Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.

Han G, Gilks CB, Leung S, Ewanowich CA, Irving JA, Longacre TA, Soslow RA.

Am J Surg Pathol. 2008 Jul;32(7):955-64. doi: 10.1097/PAS.0b013e318164edf7.

PMID:
18460981
13.

Cyclin D1 expression in dysplastic nevi: an immunohistochemical study.

Ewanowich C, Brynes RK, Medeiros L, McCourty A, Lai R.

Arch Pathol Lab Med. 2001 Feb;125(2):208-10.

PMID:
11175636
14.
15.

Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin.

Leininger E, Ewanowich CA, Bhargava A, Peppler MS, Kenimer JG, Brennan MJ.

Infect Immun. 1992 Jun;60(6):2380-5.

16.
17.

Invasion of HeLa 229 cells by virulent Bordetella pertussis.

Ewanowich CA, Melton AR, Weiss AA, Sherburne RK, Peppler MS.

Infect Immun. 1989 Sep;57(9):2698-704.

18.

Bordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture.

Ewanowich CA, Sherburne RK, Man SF, Peppler MS.

Infect Immun. 1989 Apr;57(4):1240-7.

19.

Development of a rat model for respiratory infection with Bordetella pertussis.

Woods DE, Franklin R, Cryz SJ Jr, Ganss M, Peppler M, Ewanowich C.

Infect Immun. 1989 Apr;57(4):1018-24.

Supplemental Content

Loading ...
Support Center